Replimune Corrects Warrant Ownership Cap in $150M Offering, Lowering Maximum to 19.99%

summarizeSummary

Replimune filed an amended 8-K correcting the maximum beneficial ownership threshold for pre-funded warrants issued in its $150 million offering. The cap was lowered to 19.99% from the previously stated 4.99%, giving holders more flexibility to increase their stake.

check_boxKey Events · Financing and Capital Events · REPL

• Warrant Ownership Cap Corrected

  The maximum beneficial ownership threshold a pre-funded warrant holder can elect was corrected to 19.99%, down from the previously stated 4.99% cap. This gives holders more flexibility to increase their stake without triggering the blocker.

• Offering Terms Unchanged

  The $150 million underwritten offering of 9.7 million shares and 2.7 million pre-funded warrants at $12.06 per share remains unchanged. Net proceeds are still estimated at $140.5 million.

• Amendment Filed One Day After Original

  The correction was filed on August 11, 2026, just one day after the original 8-K disclosing the offering. No other terms were amended.

auto_awesomeAnalysis · REPL · Life Sciences

This amendment to the August 10 offering disclosure corrects a key term of the pre-funded warrants: the maximum beneficial ownership threshold a holder can elect is now 19.99%, down from the previously stated 4.99% cap. This change gives investors more flexibility to increase their stake without triggering the blocker, potentially making the warrants more attractive and reducing the overhang risk of forced selling. The correction comes just one day after the original filing and does not alter the deal economics — the $150 million raise, $12.06 share price, and $140.5 million net proceeds remain unchanged.